Chikungunya Virus VLP (E1 E2 C protein) (500µg) (Special Terms Apply*)
We're always working hard to give our customers as much information on products and the best price possible. If you need any assistance or would like a quote please contact us and we will be happy to help
Chikungunya Virus VLP (E1 E2 C protein) (500µg) (Special Terms Apply*) (QTXAG-316-500) is recombinant Chikungunya Virus-Like Particles produced in mammalian HEK293 cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are totally non-infectious. >90% pure.
Chikungunya Virus VLP (Virus-Like Particle) is a unique product that has been developed in response to the need for high purity, properly assembled and glycosylated Chikungunya virus antigens for use in the development of Chikungunya virus diagnostics and in vaccine development and R&D (including use as an immunogen). Chikungunya Virus VLP is produced in human cell lines using state-of-the-art expression techniques. Chikungunya Virus VLP is constructed from E1, E2 and C proteins. Concentration and purification is then performed by a series of ultracentrifuge and chromatographical methods which result in VLPs of exceptional quality and purity. Virus-Like Particles (VLPs) are an emerging vaccine technology. *Special Terms: Please see product specification details below and our Ordering page for details.
Q-TOX Term 2: Minimum Order Volume of 1000µg on Orders Requiring Dry Ice Shipment
